Oscar-winning director Alex Gibney “will tell a Silicon Valley tale that [is] too good to be true,” in one of two films in the works documenting the Theranos saga.
View More ‘The Inventor,’ a documentary about Theranos and the ‘psychology of deception,’ will premiere at SundanceCategory: Biotech
Hospital in China denies links to world’s first gene-edited babies
News of the world’s first ever gene-edited human babies being born in China caused a huge stir on Monday after the MIT Technology Review and the Associated Press brought the project to light. People in and outside China rushed to question the ethical implications of the scientific breakthrough, reportedly the fruit of a Chinese researcher named He Jiankui from a university […]
View More Hospital in China denies links to world’s first gene-edited babiesRoivant Sciences, a four-year-old biotech holding company, just raised $200 million in fresh funding at a whopping $7 billion valuation
Roivant Sciences has had a bumpy couple of years, but that isn’t stopping investors from pouring more money into the four-year-old company, which aims to one day be a giant holding company for dozens of independent biopharmaceutical spinoffs — and is fulfilling that vision by creating one independent company at a time. Roivant’s newest financing […]
View More Roivant Sciences, a four-year-old biotech holding company, just raised $200 million in fresh funding at a whopping $7 billion valuationWatch biotech startups pitch at IndieBio’s demo day today
IndieBio, the biotech startup accelerator that’s produced heaps of notable companies (including several that have graced the Startup Battlefield), is holding its twice-annual demo day today. An even dozen young companies will be pitching their work, from AI-informed research to artificial meat, and you can watch them present live right here.
View More Watch biotech startups pitch at IndieBio’s demo day todayChina is funding the future of American biotech
Silicon Valley is in the midst of a health craze, and it is being driven by “Eastern” medicine. It’s been a record year for US medical investing, but investors in Beijing and Shanghai are now increasingly leading the largest deals for US life science and biotech companies. In fact, Chinese venture firms have invested more this […]
View More China is funding the future of American biotechuBiome is jumping into therapeutics with a healthy $83 million in Series C financing
23andMe, IBM and now uBiome is the next tech company to jump into the lucrative multi-billion dollar drug discovery market. The company started out with a consumer gut health test to check whether your intestines carry the right kind of bacteria for healthy digestion but has since expanded to include over 250,000 samples for everything […]
View More uBiome is jumping into therapeutics with a healthy $83 million in Series C financingInterview with Priscilla Chan: Her super-donor origin story
Priscilla Chan is so much more than Mark Zuckerberg’s wife. A teacher, doctor, and now one of the world’s top philanthropists, she’s a dexterous empath determined to help. We’ve all heard Facebook’s dorm-room origin story, but Chan’s epiphany of impact came on a playground. In this touching interview this week at TechCrunch Disrupt SF, Chan […]
View More Interview with Priscilla Chan: Her super-donor origin storyCB Therapeutics’ lab-grown cannabinoids could unlock new medicines and make others affordable
Marijuana may still be on shaky legal ground, but the therapeutic benefits of the psychoactive molecules — cannabinoids — inside the plant are solidly established. Unfortunately, cultivation of that plant is resource-intensive and yields only tiny amounts of some useful medicines. CB Therapeutics, a new biotech company launching today at the Disrupt SF Startup Battlefield, […]
View More CB Therapeutics’ lab-grown cannabinoids could unlock new medicines and make others affordableHP is ‘printing’ drugs for the CDC to speed up antibiotic testing
At least 2 million people in the U.S. become infected with so-called “super bugs” and at least 23,000 people die as a direct result of these infections each year, according to the Centers for Disease Control (CDC). Now, HP’s Biohacker technology is working with the CDC on a pilot program to “print” and test antibiotics […]
View More HP is ‘printing’ drugs for the CDC to speed up antibiotic testingRDMD attacks rare diseases with data mined from health records
You wouldn’t expect a medical app to get its start as a Snapchat competitor. Neither did video chat startup TapTalk’s founder Onno Faber. But four years ago he was diagnosed with a rare disease called Neurofibromatosis Type 2 that caused tumors leading Onno to lose hearing in one ear. He’s amongst the one in ten people with […]
View More RDMD attacks rare diseases with data mined from health recordsCytera Cellworks aims to bring cell culture automation to your dinner plate
Cytera Cellworks hopes to revolutionize the so-called ‘clean meat’ industry through the automation of cell cultures — and that could mean one day, if all goes to plan, the company’s products could be in every grocery store in America. Cytera is a ways off from that happening, though. Founded in 2017 by two college students in […]
View More Cytera Cellworks aims to bring cell culture automation to your dinner plateMammoth Biosciences raises $23 million for its CRISPR-based disease detection engine
Mammoth Biosciences, the biotech company that grew out of a close relationship with CRISPR legend Jennifer Doudna, has raised $23 million in a sturdy Series A. Mammoth previously raised $120,000 from NFX and the company continued quietly picking up funding as it built toward its exit from stealth mode in April 2018. Its current round […]
View More Mammoth Biosciences raises $23 million for its CRISPR-based disease detection engine